AinosAIMD
AIMD
About: Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.
Employees: 44
0
Funds holding %
of 7,431 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
0.7% less ownership
Funds ownership: 0.73% [Q1] → 0.03% (-0.7%) [Q2]
33% less funds holding
Funds holding: 12 [Q1] → 8 (-4) [Q2]
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
71% less capital invested
Capital invested by funds: $55.3K [Q1] → $16.2K (-$39.1K) [Q2]
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 5
Research analyst outlook
We haven’t received any recent analyst ratings for AIMD.
Financial journalist opinion
Based on 7 articles about AIMD published over the past 30 days
Neutral
Accesswire
3 hours ago
Water Tower Research Fireside Chat with Ainos: AI Nose Sets New Bar in AI Scent Digitization, Eyes 2026 Scale-Up
From biotech to SmellTech, Ainos transforms as a first mover in next-gen sensory AI Proprietary smell language model and scent data create unique competitive moat SmellTech flywheel spins toward 2026 scale-up, turning data into recurring revenue SAN DIEGO, CALIFORNIA / ACCESS Newswire / August 26, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a leader in AI-powered scent detection, today announced that Water Tower Research ("WTR") has published a report spotlighting AI Nose's first-mover breakthrough in giving AI the sense of smell, along with the Company's commercialization roadmap and pathway to profitability. The report draws insights from a management fireside chat on August 20, 2025.
Neutral
Accesswire
1 week ago
Water Tower Research Initiates Technology Coverage of Ainos, Highlighting Its Leadership and Advancement in AI-Powered Olfactory Innovation
Early revenues and $2.1M SmellTech-as-a-Service order set the stage for large-scale commercialization in 2026 Robotics and industrial deployments expand long-term growth runway beyond healthcare SAN DIEGO, CA / ACCESS Newswire / August 19, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a leader in AI-powered scent detection, today announced that Water Tower Research ("WTR") has assumed coverage of Ainos under its Technology research platform, transitioning from its prior coverage under the Emerging Growth category. This move underscores Ainos' strategic transformation from biotech roots to a multi-sector AI technology innovator, with its proprietary AI Nose platform poised to ignite the Company's next phase of growth across healthcare, robotics, and industrial applications.
Neutral
Accesswire
1 week ago
Ainos Debuts World's First Patented AI Nose Device, Bringing Machine Scent Intelligence to Industry and Healthcare
Patented AI Olfaction Platform Targets Semiconductor, Smart Factory, and Hospital Markets With First Deployments Underway SmellTech-as-a-Service Subscription Delivers AI Upgrades and Analytics, Keeping Enterprises Ahead in Scent Intelligence. Debuting at Automation Taipei 2025 in Partnership with Kenmec and ugo SAN DIEGO, CALIFORNIA / ACCESS Newswire / August 14, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a leader in AI-powered scent detection, today launched its first commercial AI Nose module optimized for industrial and healthcare settings, marking a pivotal milestone in the global commercialization of AI-powered digital olfaction.
Neutral
Accesswire
1 week ago
Ainos Reports Second Quarter 2025 Financial Results
1H 2025 Kicks Off AI Nose's Growing Commercial Momentum with First Senior Care Revenue and New Strategic Partnerships AI Nose 90-Day Roadmap to Power 2H 2025, with First Multi-Year $2.1M Order and Traction Across Robotics, Semiconductors, and Smart Manufacturing SAN DIEGO, CA / ACCESS Newswire / August 13, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a leader in AI-driven scent digitization, today announced its financial results for the second quarter ended June 30, 2025. Chun-Hsien (Eddy) Tsai, Chairman of the Board, President, and Chief Executive Officer of Ainos, commented, "We're thrilled that our proprietary AI-powered scent digitization platform, AI Nose, has entered the commercial execution phase.
Neutral
Accesswire
2 weeks ago
Ainos to Participate in Fireside Chat with Water Tower Research on August 20, 2025
SAN DIEGO, CALIFORNIA / ACCESS Newswire / August 11, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a pioneer in AI-powered scent detection, today announced that it will participate in a fireside chat with Robert Sassoon, senior research analyst at Water Tower Research, on Wednesday, August 20, 2025, at 11:00 a.m. ET. Ainos will highlight the uniqueness of its AI Nose technology, underscoring recent strategic partnerships and the rapid acceleration of AI Nose deployment.
Neutral
Accesswire
2 weeks ago
Ainos Secures $2.1 Million Order With ASE for First Deployment of AI Nose in Semiconductor Manufacturing Setting
First Revenue-Generating Milestone for AI Nose Smell Language Model in High-Value Industrial Applications Ainos Building Commercial Momentum with Multi-Site Deployments Underway in Japan and Taiwan SAN DIEGO, CALIFORNIA / ACCESS Newswire / August 6, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a leader in AI-powered scent digitization, today announced it has secured a three-year subscription-based order valued at $2.1 million with ASE Technology Holding Co., Ltd. ("ASEH"), the world's largest provider of semiconductor assembly and test services.
Neutral
Accesswire
3 weeks ago
Ainos Receives TFDA Approval to Initiate Clinical Study of VELDONA for Primary Sjögren's Syndrome
Advancing a Novel, Side-Effect-Free Treatment for a Rare Yet Widely Underserved Autoimmune Disease SAN DIEGO, CALIFORNIA / ACCESS Newswire / August 4, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a Texas incorporated, dual-platform AI and biotech company pioneering smelltech and immune therapeutics, today announced that its investigational low-dose oral interferon-alpha drug candidate, VELDONA®, has received formal approval from Taiwan's Food and Drug Administration (TFDA) to initiate a clinical study for primary Sjögren's syndrome (pSS). The open-label study, titled "An open-label study to evaluate the efficacy of VELDONA® in patients with primary Sjögren's Syndrome" (Study No.
Neutral
Accesswire
1 month ago
Water Tower Research Highlights Ainos' SmellTech Platform AI Nose as Foundational AI Innovation
AI Nose delivers accuracy and versatility, driving scalable growth across healthcare, industrial and robotics markets Technology, data moat, and strategic partnerships position Ainos for accelerated commercial readiness and expansion SAN DIEGO, CALIFORNIA / ACCESS Newswire / July 24, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a leader in AI-powered scent digitization, today announced that Water Tower Research has published a recap of its recent Small-Cap Spotlight podcast. The report highlights the Company's AI Nose platform, an advanced smell digitization technology powered by artificial intelligence and built on over a decade of innovation, a deep data moat, strategic partnerships, and a clear commercialization roadmap.
Neutral
Accesswire
1 month ago
Ainos and ugo Launch World's First AI Nose-Enabled Service Robot Pilots in Seven Sites Across Japan's Industrial Sector
Seven-Site Pilot Spanning Pharma, Facility Management, Energy and Utilities to Validate AI Nose as Next-Gen Industrial AI at Scale Robots Gain a New Sense: AI Nose Leverages Smell Language Model for Smart Scent Analytics SAN DIEGO, CALIFORNIA / ACCESS Newswire / July 22, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a leader in AI-driven scent digitization, today announced that ugo, Inc. ("ugo"), its first robotic partner, will pilot-deploy the world's first service robots equipped with a sense of smell powered by AI Nose at seven sites across Japan. These robots, now empowered with a new sensory modality, will operate in pharmaceutical manufacturing, facility management, energy operations, power substations, and water treatment plants, at sites operated by leading Japanese corporations.
Neutral
Accesswire
1 month ago
Ainos Regains Nasdaq Compliance, Sets 90-Day Roadmap to Scale AI Nose Platform in 2026
Commercial Momentum Accelerates with Partnerships to Drive AI-Powered Scent Intelligence for IndustrialAI and HealthcareAI SAN DIEGO, CALIFORNIA / ACCESS Newswire / July 16, 2025 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a pioneer in AI-powered scent digitization, today announced it has regained compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market. The compliance confirmation comes as Ainos gains momentum across its AI Nose platform, with strategic deployments, commercial partnerships, and a 90-day execution plan aimed at enabling large-scale commercialization by 2026.
Charts implemented using Lightweight Charts™